Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino

October 14, 2025 updated by: Baylor Research Institute
The purpose of this trial is to examine weight loss for Hispanic/Latino people with stroke (CVA) who take part in a healthy lifestyle program that has been culturally modified for Hispanic/Latino people

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Weight gain greatly increases the risk of chronic diseases such as diabetes, metabolic syndrome, pulmonary and heart disease. The Group Lifestyle Balance (GLB) intervention is a 12-month, evidence-based weight-loss program that has been used extensively with the general population and with people after CVA, however, it is not adapted to be linguistically and culturally appropriate for Latino persons post stroke. We will modified the program to meet the needs of Latino people with a CVA (GLB-CVA Latino).

Aims:

  1. : To create a modification of the CDC-recognized, evidence-based GLB-CVA to be culturally appropriate to meet the unique needs of people who identify as Hispanic/Latino, available in English and Spanish languages, using a Community-Based Participatory Research approach and AB of key stakeholders (patients, caregivers, clinicians, researchers).
  2. : Conduct a single-arm trial to describe the effect of participation in the GLB-CVA Latino on primary and secondary outcomes for 24 individuals who identify as Hispanic/Latino (12 English speakers and 12 Spanish speakers) at 3, 6, and 12 months from baseline.
  3. : Evaluate the participant compliance (feasibility) and fidelity (adherence to the DPP GLB content) with the GLB-CVA Latino intervention.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • BMI ≥25
  • Identify as Hispanic or Latino
  • 18-85 years of age
  • All types of stroke
  • Medically able to participate in a weight-loss program
  • Physical Activity Readiness Questionnaire +
  • ≥12 months post first stroke

Exclusion Criteria:

  • Contraindications for physical activity
  • Low Cognitive Function
  • Residing in hospital, acute rehab, SNF
  • Not fluent in English or Spanish
  • Pre-existing eating disorder
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GLB CVA Latino

The GLB program, adapted for Latino individuals with stroke, will be delivered to participants over a 12-month period, divided into 22 in-person or virtual, group sessions. The goal of the GLB program is to help the participant achieve and maintain a 5-7% weight-loss using a two-pronged approach:

  1. Physical activity: This is based upon recommendations by the American Heart Association and the American College of Sports Medicine (ACSM) to achieve 150 minutes of moderate intensity activity each week. Walking is the primary activity recommended.
  2. Healthy eating: Based on United States Department of Agriculture guidelines, the GLB emphasizes healthy eating patterns and tracking dietary intake. Key recommendations include individuals consuming (1) a variety of vegetables, (2) whole fruits, (3) whole grains, (4) fat-free or low-fat dairy, (5) a variety of lean proteins, and (6) oils at every meal
The Group Lifestyle Balance (GLB) program is a self-management intervention that has been shown to result in weight-loss and reduce the risk for Type 2 diabetes through increased physical activity and healthy eating behaviors in the general population. The GLB is a direct adaptation of the Diabetes Prevention Program, both developed at the Diabetes Prevention and Support Center at the University of Pittsburgh. The GLB is designed for delivery in a group-based, community setting,4 and has resulted in weight-loss in a variety of settings, such as community centers, churches, worksites, and healthcare systems.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in weight
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Weight will be measured during in-person assessments at BSWIR using a Seca 664 scale. Height will be measured using a stadiometer. Weight and height will be used to calculate BMI. A BodyTrace Smart Scale will be provided to participants to facilitate self-weighing in the home, which include cellular connectivity at no cost to participants so weight will be sent directly to the research team.
[Time Frame: Baseline, 3, 6, and 12 months]

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Circumference
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Waist circumference measured at the umbilicus and mid-upper arm circumference following ACSM guidelines.
[Time Frame: Baseline, 3, 6, and 12 months]
Height
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Will be collected using a stadiometer and used to calculate BMI
[Time Frame: Baseline, 3, 6, and 12 months]
Blood pressure
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Using an automatic cuff (average of three readings, patient seated) diastolic and systolic scores will be recorded
[Time Frame: Baseline, 3, 6, and 12 months]
8-year Diabetes Risk
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
The Framingham Heart Study diabetes risk score83 will be calculated using predictors including age, gender, fasting glucose, BMI, HDL cholesterol and triglyceride levels, blood pressure, and parental history. Risk score calculator and regression model are free and used in GLB weight-loss trials. The age range for this score is 45 years to 64 years, and therefore only individuals within this age will have calculated scores. Furthermore, the minimum cut-off score is 3.
[Time Frame: Baseline, 3, 6, and 12 months]
6 Minute Walk Test (6MWT)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity.
[Time Frame: Baseline, 3, 6, and 12 months]
10 Meter Walk Test (10MWT)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Assesses walking speed in (m/s) which is correlated to mobility in the community, capacity to perform ADLs, risk of falls, re-hospitalization, and risk of cognitive decline.
[Time Frame: Baseline, 3, 6, and 12 months]
Behavioral Risk Factor Surveillance System (BRFSS)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
The BRFSS is a state-based system of health surveys that collects information on health risk behaviors, preventative health practices, and health care access primarily related to chronic disease and injury. The GLB-TBI uses the two subscales of Healthy Eating and Physical Activity from the 2017 version of the BRFSS. It consists of 14 items.
[Time Frame: Baseline, 3, 6, and 12 months]
Neighborhood Environment Walkability Scale (NEWS)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
NEWS assesses participants' perception of neighborhood features related to physical activity and grocery shopping, including residential density, land use mix (including both indices of proximity and accessibility), street connectivity, infrastructure for walking/cycling, neighborhood aesthetics, traffic and crime safety, and neighborhood satisfaction.
[Time Frame: Baseline, 3, 6, and 12 months]
Short Assessment of Health Literacy
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Combined word recognition test and comprehension test using multiple-choice questions. Identifies individuals with low health literacy.
[Time Frame: Baseline, 3, 6, and 12 months]
Self-Rated Abilities for Health Practice
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Includes 28 items to assess health behaviors among people with disabilities and yields a total Health Practices Score plus 4 subscale scores (Exercise, Nutrition, Health Practices, and Psychological Well Being). Items are rated on a 5-point scale from 0 'not at all' to 4 'completely.' Scores range from 0-28 with higher scores indicating higher self-efficacy for the health behaviors.
[Time Frame: Baseline, 3, 6, and 12 months]
Stroke Impact Scale - Quality of Life
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Quality of life will be assessed using the Stroke Impact Scale, which assesses 8 dimensions of health-related quality of life specific to people post stroke including subscales (using a 5pt Likert scale) assessing strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function.
[Time Frame: Baseline, 3, 6, and 12 months]
Change in Exit Survey
Time Frame: [Time Frame: 12 months]
Participants will be asked to complete an exit survey at the 12-month assessment, asking about experience in, and satisfaction with, the GLB-CVA Latino (including satisfaction and feasibility with modifications and language translation) and suggestions for improvement.
[Time Frame: 12 months]
Brief Acculturation Scale for Hispanics
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
4 item language based measure of acculturation for Hispanic populations.
[Time Frame: Baseline, 3, 6, and 12 months]
Social Support for Eating Habits
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Questionnaire that assesses the frequency of support received from others for healthy eating habits over the past 3 months.
[Time Frame: Baseline, 3, 6, and 12 months]
Social Support for Physical Activity
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Questionnaire that assesses the frequency of support received from others for engaging in physical activity over the past 3 months
[Time Frame: Baseline, 3, 6, and 12 months]
HbA1c
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months. Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level. Coordinators are trained phlebotomists
[Time Frame: Baseline, 3, 6, and 12 months]
Fasting blood glucose
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months. Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level. Coordinators are trained phlebotomists
[Time Frame: Baseline, 3, 6, and 12 months]
Lipid panel
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months. Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level. Coordinators are trained phlebotomists
[Time Frame: Baseline, 3, 6, and 12 months]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Librada Callender, PhD, MPH, Baylor Scott and White Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

July 18, 2024

First Submitted That Met QC Criteria

July 18, 2024

First Posted (Actual)

July 24, 2024

Study Record Updates

Last Update Posted (Estimated)

October 15, 2025

Last Update Submitted That Met QC Criteria

October 14, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Group Lifestyle Balance

Subscribe